Arterial carboxyhemoglobin level and outcome in critically ill patients

Critical Care Medicine

Volumn 35, Issue 8, 2007, Pages 1882-1887

  Melley, Daniel D ^a   Finney, Simon J ^a   Elia, Androula ^a   Lagan, Anna L ^a   Quinlan, Gregory J ^a   Evans, Timothy W ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Carbon monoxide; Carboxyhemoglobin; Critical care; Heme oxygenase; Inflammation; Mortality

Indexed keywords

BILIRUBIN; CARBOXYHEMOGLOBIN; HEME OXYGENASE 1;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; SURVIVAL RATE;

AGED; BILIRUBIN; BIOLOGICAL MARKERS; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; CRITICAL ILLNESS; FEMALE; HEME OXYGENASE-1; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LOGISTIC MODELS; LONDON; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34547663304     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000275268.94404.43     Document Type: Article

References (50)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
2. Padkin A, Goldfrad C, Brady AR, et al: Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31:2332-2338
3. Vincent JL, Sakr Y, Sprung CL, et al: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34:344-353
4. Salvemini D, Cuzzocrea S: Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med 2002; 33:1173-1185
5. Maines MD, Gibbs PE: 30 some years of heme oxygenase: From a "molecular wrecking ball" to a "mesmerizing" trigger of cellular events. Biochem Biophys Res Commun 2005; 338:568-577
6. Ryter SW, Alam J, Choi AMK: Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol Rev 2006; 86:583-650
7. Mumby S, Upton RL, Chen Y, et al: Lung heme oxygenase-1 is elevated in acute respiratory distress syndrome. Crit Care Med 2004; 32:1130-1135
8. Philippidis P, Mason JC, Evans BJ, et al: Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: Antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 2004; 94:119-126
9. Ryter SW, Otterbein LE: Carbon monoxide in biology and medicine. Bioessays 2004; 26:270-280
10. Sedlak TW, Snyder SH: Bilirubin benefits: Cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 2004; 113:1776-1782
11. Baranano DE, Rao M, Ferris CD, et al: Biliverdin reductase: A major physiologic cytoprotectant. Proc Natl Acad Sci U S A 2002; 99:16093-16098
12. Weng Y-H, Tatarov A, Bartos BP, et al: HO-1 expression in type II pneumocytes after transpulmonary gene delivery. Am J Physiol Lung Cell Mol Physiol 2000; 278:L1273-L1279
13. Suttner DM, Dennery PA: Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J 1999; 13:1800-1809
14. Sakamoto A, Nakanishi K, Takeda S, et al: Does carboxy-hemoglobin serve as a stress-induced inflammatory marker reflecting surgical insults? J Nippon Med Sch 2005; 72:19-28
15. Yasuda H, Yamaya M, Yania M, et al: Increased blood carboxyhaemoglobin concentrations in inflammatory pulmonary diseases. Thorax 2002; 57:779-783
16. Yasuda H, Yamaya M, Nakayama K, et al: Increased arterial carboxyhemoglobin concentrations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:1246-1251
17. Morimatsu H, Takahashi T, Maeshima K, et al: Increased heme catabolism in critically ill patients: Correlation among exhaled carbon monoxide, arterial carboxyhemoglobin, and serum bilirubin IX{alpha} concentrations. Am J Physiol Lung Cell Mol Physiol 2006; 290:L114-L119
18. Hunter K, Mascia M, Eudaric P, et al: Evidence that carbon monoxide is a mediator of critical illness. Cell Mol Biol (Noisy-le-grand) 1994; 40:507-510
19. Shi Y, Pan F, Li H, et al: Carbon monoxide concentrations in paediatric sepsis syndrome. Arch Dis Child 2003; 88:889-890
20. Wald N, Idle M, Boreham J, et al: Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels. Thorax 1981; 36:366-369
21. Sears DA, Udden MM, Thomas LJ: Carboxyhemoglobin levels in patients with sickle-cell anemia: relationship to hemolytic and vasoocclusive severity. Am J Med Sci 2001; 322(6):345-8
22. Dolinay T, et al: Inhaled carbon monoxide confers antiinflammatory effects against ventilator-induced lung injury. Am J. Respir Crit Care Med 2004; 170(6):613-620
23. Otterbein LE, et al: Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6(4):422-8
24. Sarady JK, Zuckerbraun BS, Bilban M, et al: Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. FASEB J 2004; 18:854-856
25. Mazzola S, Forni M, Albertini M, et al: Carbon monoxide pretreatment prevents respiratory derangement and ameliorates hyperacute endotoxic shock in pigs. FASEB J 2005; 19:2045-2047
26. Otterbein LE, Mantell LL, Choi AM: Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 1999: 276:L688-L694
27. Mayr FB, Spiel A, Leitner J, et al: Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med 2005; 171:354-360
28. Horvath SM, Raven PB, Dahms TE, et al: Maximal aerobic capacity at different levels of carboxyhemoglobin. J Appl Physiol 1975; 38:300-303
29. Smithline HA, Ward KR, Chiulli DA, et al: Whole body oxygen consumption and critical oxygen delivery in response to prolonged and severe carbon monoxide poisoning. Resuscitation 2003; 56:97-104
30. Allred EN, Bleecker ER, Chaitman BR, et al: Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med 1989; 321:1426-1432
31. Sheps DS, Herbst MC, Hinderliter AL, et al: Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery disease. Ann Intern Med 1990; 113:343-351
32. Mayr F, Bilban M, Jilma B: Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med 2005; 171:354
33. Hampson NB, Weaver LK, Piantadosi CA: "Low-level" carbon monoxide administration may carry risk. Am J Respir Crit Care Med 2005; 172:784
34. Choi AMK, Dolinay T: "Therapeutic" carbon monoxide may be toxic. Am J Respir Crit Care Med 2005; 171:1318-1319
35. Thom SR, Weaver LK, Hampson NB: "Therapeutic" carbon monoxide may be toxic. Am J Respir Crit Care Med 2005; 171(11):1318
36. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
37. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
38. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
39. Ceriani R, Mazzoni M, Bortone F, et al: Application of the sequential organ failure assessment score to cardiac surgical patients. Chest 2003; 123:1229-1239
40. Kern H, Redlich U, Hotz H, et al: Risk factors for prolonged ventilation after cardiac surgery using APACHE II, SAPS II, and TISS: Comparison of three different models. Intensive Care Med 2001; 27:407-415
41. Pinsky MR: Dysregulation of the immune response in severe sepsis. Am J Med Sci 2004; 328:220-229
42. Moncure M, Brathwaite CE, Samaha E, et al: Carboxyhemoglobin elevation in trauma victims. J Trauma 1999; 46:424-427
43. Coburn RF, Forster RE, Kane PB: Considerations of the physiological variables that determine the blood carboxyhemoglobin concentration in man. J Clin Invest 1965; 44:1899-1910
44. Zegdi R, Caid R, Van de Louw A, et al: Exhaled carbon monoxide in mechanically ventilated critically ill patients: Influence of inspired oxygen fraction. Intensive Care Med 2000; 26:1228-1231
45. Coburn RF, Williams WJ, Kahn SB: Endogenous carbon monoxide production in patients with hemolytic anemia. J Clin Invest 1966; 45:460-468
46. Ziemann-Gimmel P, Schwartz DE: Increased carboxyhemoglobin in a patient with a large retroperitoneal hematoma. Anesth Analg 2004; 99:1800-1802
47. Scherer G: Carboxyhemoglobin and thiocyanate as biomarkers of exposure to carbon monoxide and hydrogen cyanide in tobacco smoke. Exp Toxicol Pathol 2006: 58:101-124
48. Exner M, Minar E, Wagner O, et al: The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 2004; 37:1097-1104
49. Clayton CE, Carraway MS, Suliman HB, et al: Inhaled carbon monoxide and hyperoxic lung injury in rats. Am J Physiol Lung Cell Mol Physiol 2001; 281:L949-L957
50. Griffiths MJ, Evans TW: Inhaled nitric oxide therapy in adults. N Engl J Med 2005; 353:2683-2695